Fereshteh Ashtary

Learn More
BACKGROUND Topiramate and sodium valporate are anticonvulsants, demonstrated to be effective as monotherapy for migraine prevention in placebo-controlled trials. OBJECTIVES To compare the relative efficacy of topiramate and sodium valporate in the prevention of migraine. PATIENTS AND METHODS A 24-week, randomized, double-blind, crossover, clinical trial(More)
The authors assessed the efficacy of bromocriptine in nonfluent aphasia after stroke in a 16-week, randomized, double-blind, placebo-controlled clinical trial conducted from June 2002 to April 2004. In all 38 patients after 4 months of treatment, improvement in both the bromocriptine and placebo treatment groups was observed (p < 0.001). The analysis of(More)
  • 1